cepharanthine has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubota, K; Kubota, R; Yamada, S | 2 |
| Sato, S; Takeuchi, T | 1 |
3 other study(ies) available for cepharanthine and Malignant Melanoma
| Article | Year |
|---|---|
[Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids].
Topics: Alkaloids; Benzylisoquinolines; Drug Synergism; Etoposide; Humans; Melanoma; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; Vindesine | 1992 |
[Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--II. Antimetabolite, alkylating agent, nitrosourea].
Topics: Alkaloids; Antineoplastic Agents; Benzylisoquinolines; Dacarbazine; Drug Synergism; Humans; Hydroxyurea; Melanoma; Nitrosourea Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
Effect of cepharanthine on cell-type conversion in B16 mouse melanoma cells.
Topics: Alkaloids; Animals; Benzylisoquinolines; Cell Line; Cell Survival; Cells, Cultured; Melanoma; Mice; Skin Neoplasms; Staining and Labeling | 1985 |